Observational studyESMO open2021

Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients.

M Del Re et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.